Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells

被引:23
作者
Tang, T
Arbiser, JL
Brandt, SJ
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[4] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN 37232 USA
[5] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M109812200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basic helix-loop-helix transcription factor TAL1 (or SCL), originally identified from its involvement by a chromosomal rearrangement in T-cell acute lymphoblastic leukemia, is required for hematopoietic development. TAL1 also has a critical role in embryonic vascular remodeling and is expressed in endothelial cells postnatally, although little is known about its function or regulation in this cell type. We report here that the important proangiogenic stimulus hypoxia stimulates phosphorylation, ubiquitination, and proteasomal breakdown of TAL1 in endothelial cells. Tryptic phosphopeptide mapping and chemical inhibitor studies showed that hypoxia induced the mitogen-activated protein kinase-mediated phosphorylation of a single serine residue, Ser(122), in the protein, and site-directed mutagenesis demonstrated that Ser(122) phosphorylation was necessary for hypoxic acceleration of TAL1 turnover in an immortalized murine endothelial cell line. Finally, whereas TAL1 expression was detected in endothelial cells from both large and small vessels, hypoxia-induced TAL1 turnover was observed only in microvascular endothelial cells. Besides their implications for TAL1 function in angiogenic processes, these results demonstrate that a protein kinase(s) important for mitogenic signaling is also utilized in hypoxic endothelial cells to target a transcription factor for destruction.
引用
收藏
页码:18365 / 18372
页数:8
相关论文
共 86 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   THE SCL GENE-PRODUCT - A POSITIVE REGULATOR OF ERYTHROID-DIFFERENTIATION [J].
APLAN, PD ;
NAKAHARA, K ;
ORKIN, SH ;
KIRSCH, IR .
EMBO JOURNAL, 1992, 11 (11) :4073-4081
[3]   DISRUPTION OF THE HUMAN SCL LOCUS BY ILLEGITIMATE V-(D)-J RECOMBINASE ACTIVITY [J].
APLAN, PD ;
LOMBARDI, DP ;
GINSBERG, AM ;
COSSMAN, J ;
BERTNESS, VL ;
KIRSCH, IR .
SCIENCE, 1990, 250 (4986) :1426-1429
[4]   THE SCL GENE IS FORMED FROM A TRANSCRIPTIONALLY COMPLEX LOCUS [J].
APLAN, PD ;
BEGLEY, CG ;
BERTNESS, V ;
NUSSMEIER, M ;
EZQUERRA, A ;
COLIGAN, J ;
KIRSCH, IR .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (12) :6426-6435
[5]   Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways [J].
Arbiser, JL ;
Moses, MA ;
Fernandez, CA ;
Ghiso, N ;
Cao, YH ;
Klauber, N ;
Frank, D ;
Brownlee, M ;
Flynn, E ;
Parangi, S ;
Byers, HR ;
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :861-866
[6]   DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
BASH, RO ;
HALL, S ;
TIMMONS, CF ;
CRIST, WM ;
AMYLON, M ;
SMITH, RG ;
BAER, R .
BLOOD, 1995, 86 (02) :666-676
[7]   THE GENE SCL IS EXPRESSED DURING EARLY HEMATOPOIESIS AND ENCODES A DIFFERENTIATION-RELATED DNA-BINDING MOTIF [J].
BEGLEY, CG ;
APLAN, PD ;
DENNING, SM ;
HAYNES, BF ;
WALDMANN, TA ;
KIRSCH, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10128-10132
[8]  
BERNARD O, 1991, ONCOGENE, V6, P1477
[9]   Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases [J].
Bies, J ;
Feiková, S ;
Bottaro, DP ;
Wolff, L .
ONCOGENE, 2000, 19 (24) :2846-2854
[10]  
Boyle WJ., 1991, METHOD ENZYMOL, V201, P110